Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.

2021 
Abstract Background Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    23
    References
    244
    Citations
    NaN
    KQI
    []